Results 121 to 130 of about 24,524 (277)

Stimulation of a glycosyl-phosphatidylinositol-specific phospholipase by insulin and the sulfonylurea, glimepiride, in rat adipocytes depends on increased glucose transport [PDF]

open access: yes, 1994
Korndörfer, Andrea   +7 more
core   +1 more source

Importance of Hypercortisolism in BP Control, Cardiovascular Risk and in Patients With Difficult‐to‐Control Hypertension: An Overview for Primary Care Physicians

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Hypertension remains one of the most prevalent and consequential modifiable cardiovascular risk factors worldwide, affecting approximately 1.28 billion adults globally and nearly half of the United States population. Despite the availability of effective therapies, optimal blood pressure control is achieved in fewer than one in four ...
Matthew A. Cavender
wiley   +1 more source

Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes : a meta-analysis

open access: yes, 2012
OBJECTIVE: Oral antidiabetic drugs (including metformin and sulfonylurea) may play a role in the relationship between type 2 diabetes and cancer. To quantify the association between metformin and sulfonylurea and the risk of cancer, we performed a meta-
Zambon A   +17 more
core   +1 more source

Differential Sensitivity of Maize Hybrids to Nicosulfuron

open access: yesAgronomy
Maize hybrids exhibit varying levels of tolerance to the herbicide nicosulfuron, influenced by the environment, plant developmental stage, and herbicide rate.
Natalia da Cunha Bevilaqua   +6 more
doaj   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction‐Associated Steatotic Liver Disease

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Treatment options for metabolic dysfunction‐associated steatotic liver disease (MASLD) are limited. While glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors improve cardiovascular outcomes, comparative effectiveness on liver‐related outcomes remains unclear.
Gregor A. Maier   +4 more
wiley   +1 more source

Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease

open access: yes, 2017
Despite widespread clinical use in the treatment of type 2 diabetes, the impact of sulfonylurea therapy on cardiovascular outcomes remains uncertain.
Amit V. Khera   +6 more
core   +1 more source

Enzymatic Properties and Ryegrass Resistance Mechanism to Iodosulfuron-Methyl-Sodium Herbicide

open access: yesPlanta Daninha
: Ryegrass(Lolium multiflorum)is one of the most worrisome species with regard to herbicide resistance. This study aimed at characterizing the acetolactate synthase (ALS) enzyme activity of resistant biotypes (NC and AR) and susceptible biotypes to
F. MARIANI   +5 more
doaj   +1 more source

A Four‐Week Treatment With Dapagliflozin Is Associated With a Reduction in Insulin‐Stimulated Renal Cortical Glucose Uptake: A Post Hoc Analysis From a Pilot Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Introduction and Objective Treatment with sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) reduces the risk of both cardiovascular and renal outcomes in type 2 diabetes (T2D). The specific mechanism by which this happens has not yet been clarified.
Shawn Gugliandolo   +18 more
wiley   +1 more source

Weed science education and research: the agronomy learning farm and mesotrione and sulfonylurea herbicide interactions [PDF]

open access: yes
Doctor of PhilosophyDepartment of AgronomyJohanna A. DilleThis dissertation has two complementary components: educational, in a survey of students in Weed Science and their perception of the Kansas State University Agronomy Learning farm, and research ...
Schuster, Christopher Louis
core  

Efficacy and Safety of Intensifying Once‐Weekly Insulin Icodec Treatment With Once‐Weekly Semaglutide in Adults With Type 2 Diabetes: A Single‐Arm, Open‐Label, Treat‐to‐Target, Phase 3b Trial (ONWARDS 8)

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To investigate the efficacy and safety of intensifying once‐weekly insulin icodec (icodec) with once‐weekly semaglutide in adults with type 2 diabetes (T2D). Materials and Methods ONWARDS 8 was a single‐arm, open‐label, treat‐to‐target, Phase 3b trial comprising a 26‐week icodec run‐in period and a 26‐week semaglutide intensification ...
Krzysztof Strojek   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy